Essity AB (ESSITY-B.ST) is a leading global hygiene and health company headquartered in Stockholm, Sweden. The company operates in three segments: Personal Care, Tissue, and Health & Medical. With well-known brands such as TENA, Libero, and Tork, Essity has a strong market position in both developed and emerging markets.
Investment Thesis: Essity is a classic consumer compounder with a history of steady revenue growth, expanding margins, and strong cash flow generation. The company benefits from secular trends such as aging populations (increasing demand for incontinence products), rising hygiene awareness, and premiumization in emerging markets. Recent restructuring and cost-saving initiatives are expected to drive margin improvement, while a strong balance sheet supports both organic investments and shareholder returns.
12-Month Catalysts:
- Margin expansion from cost-saving programs and operational efficiency improvements.
- Revenue acceleration in emerging markets, particularly in Asia and Latin America.
- Potential divestiture of non-core assets or further portfolio optimization.
- Continued innovation in sustainable products, driving premium pricing.
Key Risks:
- Raw material cost inflation (pulp, energy) could pressure margins.
- Currency headwinds, especially in emerging markets, could impact reported earnings.
Valuation Summary: Essity trades at approximately 16x forward P/E, a discount to its historical average and to peers like Kimberly-Clark. With expected EPS growth of 8-10% over the next two years, the valuation appears attractive for a high-quality consumer staple.
Balance Sheet Summary: Essity has a strong balance sheet with net debt/EBITDA of around 1.5x, investment-grade credit ratings, and robust free cash flow generation. The company has a consistent dividend payout and active share buyback program.
Disclaimer: This is not personalized financial advice. Please conduct your own research or consult a financial advisor before making investment decisions.